National Institute on Aging (NIA)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute on Aging (NIA) sits in the top decile of US sponsors by registered trial count (#209 of 15,742 sponsors by registered trial count).
National Institute on Aging (NIA): 131 sponsored US clinical trials, 12 recruiting.
National Institute on Aging (NIA) sponsors 131 registered US clinical trials on ClinicalTrials.gov, 12 of them currently recruiting, and 103 completed. 18 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aging, with 7 trials.
Top-decile sponsor footprint
National Institute on Aging (NIA) ranks in the top decile of sponsors by registered trial count (#209 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
103 of 116 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
131 total, page 1 of 3
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
NCT06274749
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
NCT07099053
Pediatric Neuroimaging
NCT06912724
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide
NCT06269653
Collection of Bone Marrow Aspirate From Normal Volunteers
NCT03949647
Taste Bud-Derived Stem Cells in Humans
NCT03366168
Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)
NCT02339012
Baltimore Longitudinal Study of Aging
NCT00233272
Development of 3T Magnetic Resonance Research Methods for NIA Studies
NCT01324206
Genetic Characterization of Movement Disorders and Dementias
NCT02014246
Tissue Procurement for Biomedical Research
NCT00182858
Cytapheresis of Volunteer Donors
NCT00104325
A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans
NCT04852289
Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans
NCT04565067
Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS)
NCT01323322
Deprescribing Potentially Inappropriate Medications in the Emergency Department for Persons Living With Dementia
NCT06273917
Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults 55 Years Old or Older
NCT04421014
Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production
NCT03852901
Study of Skin Cells That Stop Replicating (Senescent) During Wound Healing
NCT02755584
Resveratrol and Cardiovascular Health in the Elderly
NCT01842399
Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function
NCT02460783
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
NCT02363335
Bisnorcymserine in Healthy Adult Volunteers
NCT01747213
Calcium Channel Splice Variant Expression in Cardiovascular Disease and Aging
NCT00251615
Mechanisms Accounting for Unexplained Anemia in the Elderly
NCT01572506
The Role of Endocannabinoids in Insulin Production and Action
NCT01517100
Age-Related Changes in Body Composition
NCT01517113
Initial Study of Fenoterol as a Treatment for Heart Failure
NCT01440335
CARDIA Brain MRI Substudy
NCT01273311
A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
NCT01255163
Muscle Biopsies in Healthy Volunteers
NCT01431677
Safety and Tolerability of the Derma Vax(Trademark) Clinical Intradermal Electroporation System in Healthy Subjects
NCT01324843
The Relationship Between Uric Acid and Inflammatory Markers
NCT01323335
Androgen Deprivation Therapy Study
NCT00743327
AMS Study: Inflammatory and Biomechanical Contributors to Arthritis Development Following Arthroscopic Meniscectomy
NCT00752271
A Prospective Study of Postpartum Depression in Women With Major Depression
NCT01328613
Improving Depression Treatment for Older Minority Adults
NCT00570427
Exercise, Executive Processes and the Aging Brain
NCT00430976
Growth Hormone Administration and the Human Immune System
NCT00663611
Proximity Alarms to Reduce Patient Falls
NCT00183053
Breathe: Slow Paced Breathing to Lower Blood Pressure
NCT00328016
An Intervention to Increase Physical Activity Among African American Women
NCT00473044
Anti-Oxidant Treatment of Alzheimer's Disease
NCT00117403
Etiology of Anemia
NCT00302939
REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction
NCT00378352
Caminemos! Trial to Increase Walking Among Sedentary Older Latinos
NCT00183014
Memory Imaging of Normal Aging
NCT00315575
A Study of the Function of Hormones Present In Taste Buds
NCT00233298
Alzheimer's Caregiver Communication Study
NCT00182988
Osteopuncture for Osteoarthritis-Associated Knee Pain & Disability
NCT00417313
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 18 |
| Phase 2 | 20 |
| Phase 3 | 14 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the National Institute on Aging (NIA) pipeline
12 recruiting of 131 indexed (9% open); 103 completed (79%).
Phase mix: 18 late (III/IV) vs 38 early (I/II) (early-phase heavy).
Top condition: Aging (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute on Aging (NIA): open-pipeline peers nationwide
Peers matched on 131 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
National Institute on Aging (NIA) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 131 trials (± recruiting share)
- Rhode Island Hospital · 130 trials · 20% recruiting
- George Washington University · 133 trials · 18% recruiting
- University of Illinois at Urbana-Champaign · 129 trials · 14% recruiting
- Jazz Pharmaceuticals · 128 trials · 12% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Alkermes · 9% recruiting · 66 trials
- DBV Technologies · 9% recruiting · 11 trials
- Florida Gulf Coast University · 9% recruiting · 11 trials
- Genfit · 9% recruiting · 11 trials
Related
What to do with this National Institute on Aging (NIA) page
131 registered trials is a research-attention snapshot, not an endorsement of National Institute on Aging (NIA) or any single study.
- 12 of National Institute on Aging (NIA)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aging is the condition National Institute on Aging (NIA) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aging trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
National Institute on Aging (NIA) pipeline card: 131 registered trials from official public datasets.Report a data error.